Subsequent Events	3 Months Ended
Apr. 30, 2025
Subsequent Events [Abstract]
Subsequent Events	Note 9 — Subsequent Events The Company evaluated subsequent events and transactions that occurred after the balance sheet date through the date when these financial statements were issued. Based on this review, the Company did not identify any other subsequent events, other than discussed below, that would require adjustment or disclosure in the financial statements. On May 19, 2025, the Company further modified the following key terms of the Proposed Public Offering to decrease the number of Private Placement Units to be purchased by the Sponsor if the underwriters’ over-allotment option is exercised in full from 217,641 units to 212,500 units at a price of $10.00 per unit for an aggregate purchase price of $2,125,000. On May 27, 2025, the Company consummated its IPO of 7,500,000 Units at an offering price of $10.00 per Unit generating gross proceeds of $75,000,000. Simultaneously with the closing of the IPO, the Company sold 276,250 Private Placement Unit at a price of $10.00 per Private Placement Unit to the Sponsor and EBC in a private placement generating total gross proceeds of $2,762,500. On May 27, 2025, the Company repaid the outstanding Promissory Note balance of $700,000 to the Sponsor upon the closing of the IPO. On May 28, 2025, the underwriters notified the Company of their exercise of the over-allotment option in full to purchase 1,125,000 additional units (the “Option Units”) at $10.00 per unit. The closing of the issuance and sale of the Option Units occurred on May 30, 2025 generated total gross proceeds of $11,250,000. Simultaneously with the closing of the over-allotment option, the Company consummated the private placement of an aggregate of 22,500 Private Placement Units to the Sponsor and EBC, at a price of $10.00 per Private Placement Unit, generating gross proceeds of $225,000.

Subsequent Events

3 Months Ended

Apr. 30, 2025

Note 9 — Subsequent Events

The Company evaluated subsequent events and transactions that occurred after the balance sheet date through the date when these financial statements were issued. Based on this review, the Company did not identify any other subsequent events, other than discussed below, that would require adjustment or disclosure in the financial statements.

On May 19, 2025, the Company further modified the following key terms of the Proposed Public Offering to decrease the number of Private Placement Units to be purchased by the Sponsor if the underwriters’ over-allotment option is exercised in full from 217,641 units to 212,500 units at a price of $10.00 per unit for an aggregate purchase price of $2,125,000.

On May 27, 2025, the Company consummated its IPO of 7,500,000 Units at an offering price of $10.00 per Unit generating gross proceeds of $75,000,000. Simultaneously with the closing of the IPO, the Company sold 276,250 Private Placement Unit at a price of $10.00 per Private Placement Unit to the Sponsor and EBC in a private placement generating total gross proceeds of $2,762,500.

On May 27, 2025, the Company repaid the outstanding Promissory Note balance of $700,000 to the Sponsor upon the closing of the IPO.

On May 28, 2025, the underwriters notified the Company of their exercise of the over-allotment option in full to purchase 1,125,000 additional units (the “Option Units”) at $10.00 per unit. The closing of the issuance and sale of the Option Units occurred on May 30, 2025 generated total gross proceeds of $11,250,000. Simultaneously with the closing of the over-allotment option, the Company consummated the private placement of an aggregate of 22,500 Private Placement Units to the Sponsor and EBC, at a price of $10.00 per Private Placement Unit, generating gross proceeds of $225,000.